233 related articles for article (PubMed ID: 19455593)
1. A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.
Morizono K; Xie Y; Helguera G; Daniels TR; Lane TF; Penichet ML; Chen IS
J Gene Med; 2009 Aug; 11(8):655-63. PubMed ID: 19455593
[TBL] [Abstract][Full Text] [Related]
2. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
3. Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules.
Situ K; Chua BA; Bae SY; Meyer AS; Morizono K
Virology; 2018 Dec; 525():170-181. PubMed ID: 30290312
[TBL] [Abstract][Full Text] [Related]
4. Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins.
Morizono K; Pariente N; Xie Y; Chen IS
J Gene Med; 2009 Jul; 11(7):549-58. PubMed ID: 19434609
[TBL] [Abstract][Full Text] [Related]
5. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
Campos SK; Parrott MB; Barry MA
Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
[TBL] [Abstract][Full Text] [Related]
6. Avidin fusion protein-expressing lentiviral vector for targeted drug delivery.
Lesch HP; Pikkarainen JT; Kaikkonen MU; Taavitsainen M; Samaranayake H; Lehtolainen-Dalkilic P; Vuorio T; Määttä AM; Wirth T; Airenne KJ; Ylä-Herttuala S
Hum Gene Ther; 2009 Aug; 20(8):871-82. PubMed ID: 19419273
[TBL] [Abstract][Full Text] [Related]
7. Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.
Purow B; Staveley-O'Carroll K
J Surg Res; 2005 Jan; 123(1):49-54. PubMed ID: 15652950
[TBL] [Abstract][Full Text] [Related]
8. Targeting and purification of metabolically biotinylated baculovirus.
Kaikkonen MU; Viholainen JI; Närvänen A; Ylä-Herttuala S; Airenne KJ
Hum Gene Ther; 2008 Jun; 19(6):589-600. PubMed ID: 18479188
[TBL] [Abstract][Full Text] [Related]
9. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification.
Parrott MB; Adams KE; Mercier GT; Mok H; Campos SK; Barry MA
Mol Ther; 2003 Oct; 8(4):688-700. PubMed ID: 14529842
[TBL] [Abstract][Full Text] [Related]
10. Avidin-biotin interaction mediated peptide assemblies as efficient gene delivery vectors for cancer therapy.
Qu W; Chen WH; Kuang Y; Zeng X; Cheng SX; Zhou X; Zhuo RX; Zhang XZ
Mol Pharm; 2013 Jan; 10(1):261-9. PubMed ID: 23146022
[TBL] [Abstract][Full Text] [Related]
11. Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation.
Nesbeth D; Williams SL; Chan L; Brain T; Slater NK; Farzaneh F; Darling D
Mol Ther; 2006 Apr; 13(4):814-22. PubMed ID: 16298167
[TBL] [Abstract][Full Text] [Related]
12. Enhanced gene delivery by avidin-displaying baculovirus.
Räty JK; Airenne KJ; Marttila AT; Marjomäki V; Hytönen VP; Lehtolainen P; Laitinen OH; Mähönen AJ; Kulomaa MS; Ylä-Herttuala S
Mol Ther; 2004 Feb; 9(2):282-91. PubMed ID: 14759812
[TBL] [Abstract][Full Text] [Related]
13. Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types.
Kasaraneni N; Chamoun-Emanuelli AM; Wright G; Chen Z
mBio; 2017 Dec; 8(6):. PubMed ID: 29233896
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.
Zhang XY; Kutner RH; Bialkowska A; Marino MP; Klimstra WB; Reiser J
Retrovirology; 2010 Jan; 7():3. PubMed ID: 20100344
[TBL] [Abstract][Full Text] [Related]
16. Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.
Morizono K; Ku A; Xie Y; Harui A; Kung SK; Roth MD; Lee B; Chen IS
J Virol; 2010 Jul; 84(14):6923-34. PubMed ID: 20484510
[TBL] [Abstract][Full Text] [Related]
17. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
Campos SK; Barry MA
Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
[TBL] [Abstract][Full Text] [Related]
18. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes.
Arnold GS; Sasser AK; Stachler MD; Bartlett JS
Mol Ther; 2006 Jul; 14(1):97-106. PubMed ID: 16624620
[TBL] [Abstract][Full Text] [Related]
19. Development of adenovirus immobilization strategies for in situ gene therapy.
Hu WW; Lang MW; Krebsbach PH
J Gene Med; 2008 Oct; 10(10):1102-12. PubMed ID: 18618417
[TBL] [Abstract][Full Text] [Related]
20. Avidin-biotin technology in targeted therapy.
Lesch HP; Kaikkonen MU; Pikkarainen JT; Ylä-Herttuala S
Expert Opin Drug Deliv; 2010 May; 7(5):551-64. PubMed ID: 20233034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
